Clinical Trial Update: 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 9 mg budesonide once daily to 3 mg budesonide three times daily in active Crohn's disease has completed. The study was sponsored by Dr. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Crohn´s Disease | Phase 3 | Status: COMPLETED